APP and Alzheimer disease: A similar study showed that Neuroblastoma Differentiation Marker 29 (NDM29), a RNA polymerase III-dependent noncoding RNA, enhances the synthesis of amyloid precursor protein, eventually resulting in an increase of Aβ secretion that promotes the formation of Aβ peptides as they may occur in Alzheimer's disease [18].